Neurology. Charles H. Clarke

Чтение книги онлайн.

Читать онлайн книгу Neurology - Charles H. Clarke страница 26

Neurology - Charles H. Clarke

Скачать книгу

cause congenital insensitivity to pain.

      Calcium Channels

      Calcium channels are structurally similar to sodium channels, though with slower kinetics. There are three groups:

       CaV1.1, one of the L‐type channels has a central role in excitation–contraction coupling in skeletal muscle.

       P/Q type channels contribute to triggering neurotransmitter release at presynaptic terminals and are also expressed in the cerebellar cortex.

       Transiently activating T‐type, low threshold channels have a role in burst‐firing of thalamic neurones.

      Loss‐of‐function mutations of CACNA1A, which encodes the pore‐forming subunit of the CNS calcium channel CaV2.1, cause episodic ataxia type 2, while gain‐of‐function mutations cause familial hemiplegic migraine.

      Chloride and Ligand‐Gated Ion Channels

      In skeletal muscle, dimeric ClC‐2 channels have an important role in setting the resting membrane potential. They activate further upon depolarisation. Loss‐of‐function mutations destabilise the membrane potential and predispose to repetitive discharges. Both dominantly inherited and recessive mutations occur – Thomsen and Becker myotonia.

      Ligand‐gated ion channels mediate fast neurotransmission. Many mutations have been identified.

      Acetylcholine Receptors

      At the neuromuscular junction ACh opens nicotinic receptors made up of α1, β1, δ and ε subunits, encoded by CHRNA1, CHRNB1, CHRND and CHRNE. Mutations of these subunits can cause a congenital myasthenic syndrome.

      Of the receptor subunits expressed in the CNS, mutations have been identified in CHRNA4, CHRNA2 and CHRNB2 (encoding the α4, α2 and β2 subunits, respectively) in autosomal dominant nocturnal frontal lobe epilepsy. CNS nicotinic receptors mediate fast excitatory transmission to a subset of cortical interneurones. How mutations give rise to epilepsy remains unclear.

      GABAA, Glycine and Glutamate Receptors

      GABAA receptors are structurally homologous to nicotinic receptors but are permeable to chloride ions instead of sodium and potassium. They mediate fast inhibitory transmission and are the sites of action of benzodiazepines and other anti‐epileptic, and anxiolytic drugs. Loss‐of‐function mutations have been reported in epilepsy.

      Glycine receptors also homologous to GABAA mediate fast inhibition in the spinal cord and brainstem. AD or AR loss‐of‐function mutations of GLRA1 cause familial hyperekplexia.

      Glutamate receptors mutations have been described in schizophrenia, and in rolandic epilepsy.

      Acquired Channelopathies

      I am most grateful to Dimitri Kullmann, Henry Houlden & Michael Lunn for their contribution to Neurology A Queen Square Textbook Second Edition on which this chapter was based. I am also indebted to Simon Farmer & David Choi who wrote in Chapter 16 about spinal embryology in Neurology A Queen Square Textbook Second Edition.

      1 Kullman D, Houlden H, Lunn M. Mechanisms of neurological disease: genetics, autoimmunity and ion channels. In Neurology A Queen Square Textbook, 2nd edn. Clarke C, Howard R, Rossor M, Shorvon S, eds. John Wiley & Sons, 2016. There are numerous references.

      Also, please visit https://www.drcharlesclarke.com for free updated notes, potential links and references as these become available. You will be asked to log in, in a secure fashion, with your name and institution.

      My purpose here is to outline how I approach day‐to‐day neurology:

       To provide a framework for examination, diagnosis and investigation

       To introduce terminology – the language and vocabulary we use.

      There is some distance between anatomy, science, diagnosis and the words we use to communicate clinical features. I try to fill these gaps. Our first purpose is to answer one question: is there a recognisable disease? In no other speciality are clinical patterns more important, nor are they more reliable. Despite advances in imaging, neurogenetics and neuropathology, we follow a traditional approach:

       Assemble clinical observations – history, symptoms and physical signs, and assess investigations.

       Recognise, by sifting these, the site of the problem, and if possible a disease.

      Good neurology is about getting this right. Failure to follow this approach can lead to over‐investigation or missing a serious disease.

      Diagnosis is the product of the history and examination. Many find neurology hard, both because of this interplay and also because of its breadth. In some conditions, such as migraine, a faint or a seizure, we rely on narratives. There are typically no physical signs. In others, examination is pivotal, for example signs of a spastic paraparesis. However, despite its sophistication the nervous system has a relatively limited repertoire. For example, a headache can be similar whether the problem is benign or sinister.

      Try

Скачать книгу